Assessment of setup accuracy in patients receiving postmastectomy radiotherapy using electronic portal imaging

被引：8
作者：
Koseoglu F.G. [1 ]
Tuncel N. [1 ]
Kizildag A.U. [1 ]
Garipagaoglu M. [1 ,4 ]
Adli M. [2 ]
Andic C. [3 ]
机构：
[1] Department of Radiation Oncology, Akdeniz University School of Medicine, Antalya
[2] Gaziantep University School of Medicine, Department of Radiation Oncology, Gaziantep
[3] Akdeniz University School of Medicine, Department of Radiology, Antalya
[4] Acibadem Oncology and Neurological Science Hospital, Kozyataǧi
来源：
Radiation Medicine | 2007年 / 25卷 / 2期
关键词：
Breast cancer; EPI (electronic portal imaging); Radiotherapy; Setup accuracy;
D O I：
10.1007/s11604-006-0102-6
中图分类号：
学科分类号：
摘要：
Purpose. The aim of this study was to investigate the setup accuracy for patients undergoing postmastectomy radiotherapy using electronic portal imaging. Materials and methods. Ten patients undergoing radiotherapy via tangent (TG), supraclavicular-axillary (SA), and internal mammary (IM) fields were included. To explore the setup accuracy, distances between chosen landmarks were taken as reference parameters (RPs). The difference between measured RPs on simulation films and electronic portal images (EPIs) was calculated as the setup error. Results. A total of 30 simulation films and 120 EPIs were evaluated. In the SA field, calculated RPs were lung length (LL), clavicle-field center perpendicular distance, and clavicle-field center transverse distance. The mean of the standard deviations (SDs) of the random errors (σ) for these parameters were 4.7, 7.3, and 7.6; and the SDs of the systematic errors (∑) were 6.8, 4.4, and 13.5, respectively. In the TG fields, the calculated RPs were the central lung distance (CLD), maximum lung distance (MLD), and central soft-tissue distance (CSTD). In the medial TG field, the σ values for these parameters were 3.4, 3.6, and 4.1, respectively; and the σ values were 6.6, 2.6, and 3.4, respectively. In the lateral TG field, ∑ values for the calculated RPs were 2.4, 3.2, and 3.3l, respectively; and the ∑ values were 5.6, 3.6, and 4.8, respectively. Conclusion. CLD, MLD, and CSTD in TG fields and LL in SA fields are easily identifiable and are helpful for detecting setup errors using EPIs in patients undergoing postmastectomy radiotherapy. © 2007 Japan Radiological Society.
引用
收藏
页码：45 / 52
页数：7
相关论文
共 26 条
  • [1] Overgaard M., Hansen P.S., Overgaard J., Rose C., Andersson M., Bach F., Et al., Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b Trial, N Engl J Med, 337, pp. 949-55, (1997)
  • [2] Ragaz J., Jackson S.M., Le N., Plenderleith I.H., Spinelli J.J., Basco V.E., Et al., Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer, N Engl J Med, 337, pp. 956-62, (1997)
  • [3] Smith I.C., Heys S.D., Hutcheon A.W., Miller I.D., Payne S., Gilbert F.J., Et al., Neoadjuvant chemotherapy in breast cancer: Significantly enhanced response with docetaxel, J Clin Oncol, 20, pp. 1456-66, (2002)
  • [4] Misset J.L., Di Palma M., Delgado M., Plagne R., Chollet P., Fumoleau P., Et al., Adjuvant treatment of node-positive breast cancer with cyclophosphamide, doxorubicin, fluorouracil, and vincristine versus cyclophosphamide, methotrexate, and fluorouracil: Final report after a 16-year median follow-up duration, J Clin Oncol, 14, pp. 1136-45, (1996)
  • [5] O'Shaughnessy J., Miles D., Vukelja S., Moiseyenko V., Ayoub J.P., Cervantes G., Et al., Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: Phase III trial results, J Clin Oncol, 20, pp. 2812-23, (2002)
  • [6] Hurkmans C.W., Cho B.C., Damen E., Zijp L., Mijnheer B.J., Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation, Radiother Oncol, 62, pp. 163-71, (2002)
  • [7] Landau D., Adams E.J., Webb S., Ross G., Cardiac avoidance in breast radiotherapy: A comparison of simple shielding techniques with intensity-modulated radiotherapy, Radiother Oncol, 60, pp. 247-55, (2001)
  • [8] Hojris I., Overgaard M., Christensen J.J., Overgaard J., Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: Analysis of DBCG 82b and 82c randomised trials: Radiotherapy Committee of the Danish Breast Cancer Cooperative Group, Lancet, 354, pp. 1425-30, (1999)
  • [9] Lingos T.I., Recht A., Vicini F., Abner A., Silver B., Harris J.R., Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy, Int J Radiat Oncol Biol Phys, 21, pp. 355-60, (1991)
  • [10] Hardenbergh P.H., Bentel G.C., Prosnitz L.R., Marks L.B., Postmastectomy radiotherapy: Toxicities and techniques to reduce them, Semin Radiat Oncol, 9, pp. 259-68, (1999)
123